Trial intelligence / Profile preview

Compeed Cold Sore Patch vs Zovirax Cream for Herpes Labialis

2006-004015-21Phase 4Completed

Sponsor
Johnson & Johnson
Start
Aug 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in herpes labialis comparing Compeed Cold Sore Patch with Zovirax Cream 5% (2 arms). Primary endpoint: Subject global assessment at end of therapy. Started Aug 2006; status: completed.

02

Drugs

Compeed Cold Sore Patchaciclovir
03

Conditions

herpes labialis

Beyond the preview

Go deeper on 2006-004015-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004015-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call